Horacio Bach, Greg Rosenfeld, Brian Bressler. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Anti-Inflammatory Agents, Non-Steroidal/administration & dosageAnti-Inflammatory Agents, Non-Steroidal/therapeutic useAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/therapeutic useBacterial Proteins/immunologyBacterial Proteins/metabolismCrohn Disease/complicationsCrohn Disease/drug therapyHumansImmunogenetic PhenomenaInfliximabMacrophages/immunologyMacrophages/metabolismMacrophages/microbiologyMycobacterium avium subsp. paratuberculosis/metabolismParatuberculosis/complicationsParatuberculosis/drug therapyParatuberculosis/microbiologyTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Anti-Inflammatory Agents, Non-SteroidalAntibodies, MonoclonalBacterial ProteinsTumor Necrosis Factor-alphaInfliximab
Year: 2012 PMID: 22398081 DOI: 10.1016/j.crohns.2012.01.011
Source DB: PubMed Journal: J Crohns Colitis ISSN: 1873-9946 Impact factor: 9.071